{"id":"https://openalex.org/W71384224","doi":null,"title":"[Stage IV NSCLC. Second-line therapy for metastatic non-small cell lung cancer].","display_name":"[Stage IV NSCLC. Second-line therapy for metastatic non-small cell lung cancer].","publication_year":2008,"publication_date":"2008-10-01","ids":{"openalex":"https://openalex.org/W71384224","mag":"71384224","pmid":"https://pubmed.ncbi.nlm.nih.gov/18971835"},"language":"fr","primary_location":{"id":"pmid:18971835","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18971835","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revue des maladies respiratoires","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008724268","display_name":"\u00c9lisabeth Quoix","orcid":"https://orcid.org/0000-0001-5131-9562","observed_orcids":["https://orcid.org/0000-0001-5131-9562"]},"institutions":[{"id":"https://openalex.org/I4210145324","display_name":"H\u00f4pitaux Universitaires de Strasbourg","ror":"https://ror.org/04bckew43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210145324"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"E Quoix","raw_affiliation_strings":["Service de Pneumologie, H\u00f4pitaux Universitaires de Strasbourg, 1 place de l'H\u00f4pital, Strasbourg cedex, France. elisabeth.quoix@chru-strasbourg.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Pneumologie, H\u00f4pitaux Universitaires de Strasbourg, 1 place de l'H\u00f4pital, Strasbourg cedex, France. elisabeth.quoix@chru-strasbourg.fr","institution_ids":["https://openalex.org/I4210145324"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5008724268"],"corresponding_institution_ids":["https://openalex.org/I4210145324"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.01474679,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"25","issue":"8 Pt 2","first_page":"3S113","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-nsclc","display_name":"metastatic non-small cell lung cancer","score":0.9229999780654907},{"id":"https://openalex.org/keywords/second-line-chemotherapy","display_name":"second-line chemotherapy","score":0.9599999785423279},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9810000061988831},{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":1.0},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.9760000109672546},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9300000071525574},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.9399999976158142},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.5450000166893005}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.9444398880004883},{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.8357813358306885},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8357257843017578},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.8187379240989685},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7180627584457397},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6526231169700623},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6332131624221802},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6300376057624817},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.44867420196533203},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36703187227249146},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.21906524896621704},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.09851652383804321}],"mesh":[{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:18971835","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18971835","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revue des maladies respiratoires","raw_type":"English Abstract"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2272416128","https://openalex.org/W2094314204","https://openalex.org/W2411232948","https://openalex.org/W2169511187","https://openalex.org/W2391528254","https://openalex.org/W2001780500","https://openalex.org/W2042846576","https://openalex.org/W2404692521","https://openalex.org/W1966598656","https://openalex.org/W2164661224"],"abstract_inverted_index":{"Second":[0],"line":[1,124],"chemotherapy":[2,139],"for":[3,135],"advanced":[4],"non":[5],"small":[6,93],"cell":[7,88],"lung":[8,89],"cancer":[9,90],"is":[10,131],"a":[11,55,97,112],"recent":[12],"concept":[13],"as":[14],"the":[15,29,40,60,84,92,106],"first":[16,30],"phase":[17],"III":[18],"studies":[19],"demonstrating":[20],"its":[21],"efficacy":[22,71],"were":[23],"published":[24],"in":[25,36,54,83,120,141,148],"2000.":[26],"Docetaxel":[27],"was":[28,50],"agent":[31],"explored":[32],"and":[33,68,91],"deemed":[34],"efficient":[35],"this":[37,128],"setting":[38],"at":[39,59],"dose":[41,61,98],"of":[42,62,86,99,109,115,125,138],"75":[43],"mg/m2":[44,64],"every":[45,65],"3":[46,66],"weeks.":[47],"Then":[48],"pemetrexed":[49],"compared":[51,117],"to":[52,118],"docetaxel":[53],"non-inferiority":[56],"randomized":[57],"trial":[58],"500":[63],"weeks":[67],"demonstrated":[69,111],"similar":[70],"with":[72],"significantly":[73],"less":[74],"toxicity":[75],"than":[76],"docetaxel.":[77],"Targeted":[78],"therapies":[79],"undergo":[80],"exponential":[81],"development":[82],"treatment":[85],"non-small":[87],"molecule":[94],"erlotinib":[95],"(at":[96],"150":[100],"mg/day":[101],"per":[102],"os)":[103],"which":[104],"inhibits":[105],"tyrosine":[107],"kinase":[108],"EGF-R":[110],"significant":[113],"benefit":[114],"survival":[116],"placebo":[119],"second":[121],"or":[122],"third":[123],"chemotherapy.":[126],"At":[127],"time":[129],"there":[130],"no":[132],"specific":[133],"recommendations":[134],"further":[136],"lines":[137],"although":[140],"clinical":[142],"practice,":[143],"they":[144],"are":[145],"currently":[146],"used":[147],"good":[149],"performance":[150],"status":[151],"patients.":[152]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}